Embed Size (px)
Citation preview
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
Biotechnology Industry Overview and Growth Strategy Framework
Forward Integration Creates Opportunity For Superior Profit Margins
“There exists strong evidence that biotechnology companies' forward integration efforts are justified not only by the potential for revenue growth, but also by opportunity for high profit margins. ”
Lab Instrumentation & Products Analyst Team
Frost & Sullivan
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
Frost & Sullivan provides:
• Detailed insights into recent developments and trends
• Drivers, restraints, challenges, and strategic recommendations
• Analyst insights on ‘hot topics’ and emerging applications in the biotechnology industry
• Market sizing and competitive analysis
• Market forecasts and opportunity analysis
• Quarterly assessments
• End-user analysis within each report
Key Features
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
• Coverage: The United States
• Proven methodology encompassing extensive primary and secondary data and research
• Focused information and strategies that cover business and technology issues
• Credible data and analysis highlighting industry dynamics
• Winning strategies to help you create precise business plans
What We Offer
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
Current Market Participants• Find out how you compare to the competition• Assess current and future drivers and restraints• Determine and exploit new market share opportunities
New Entrants • Analyze challenges associated with the industry• Calculate time scales for strategy implementation• Position yourself to capitalize on the market’s unmet needs
Investment Community• Analyze long-term strategies of companies• Determine which participants will outperform the competition• Assess attractiveness of investing in the market
Who Will Benefit?
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
Abgenix, Inc.Acambis Plc.Actelion Ltd.Active Biotech ABAdvanced Tissue Sciences, Inc.AEterna Laboratories, Inc.Agenix Ltd.Alexion Pharmaceuticals, Inc.Amgen, Inc.Amrad Corp., Ltd.Anika Therapeutics, Inc.Avanir PharmaceuticalsBioCryst Pharmaceuticals, Inc.Biogen, Inc.BioMarin Pharmaceutical, Inc.Bioniche Life Sciences, Inc.Biosearch Italia SpABio-Technology General Corp.Cambridge Antibody Technology Group Plc.Cangene Corp.Carrington Laboratories, Inc.
Key Market ParticipantsCelgene Corp.Cell Genesys, Inc.Cephalon, Inc.Chiron Corp.Corixa Corp.Crucell NVCytogen Corp.Dendreon Corp.Dyax Corp.Enzo Biochem, Inc.Enzon, Inc.Epimmune, Inc.Essential Therapeutics, Inc.Genentech, Inc.Genesis Research and Development Corp., Ltd.Genentech, Inc.Genome Therapeutics Corp.Genzyme Corp.Gilead Sciences, Inc.GTC Biotherapeutics, Inc.Guilford Pharmaceuticals, Inc.Haemacure Corp.
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
Human Genome Sciences, Inc.Icos Corp.IDEC Pharmaceuticals Corp.Ilex Oncology, Inc.ImClone Systems, Inc.Immunomedics, Inc.Indevus Pharmaceuticals, Inc.Inspire Pharmaceuticals, Inc.Integra LifeSciences Holdings Corp.InterMune, Inc.Isis Pharmaceuticals, Inc.LifeCell Corp.Ligand Pharmaceuticals, Inc.Maxygen, Inc.Medarex, Inc.MedImmune, Inc.Millennium Pharmaceuticals, Inc.Myriad Genetics, Inc.NaPro BioTherapeutics, Inc.Neurocrine Biosciences, Inc.Nexell Therapeutics, Inc.Novavax, Inc.Novogen Ltd.
Key Market Participants (cont’d)NPS Pharmaceuticals, Inc.Onyx Pharmaceuticals, Inc.Organogenesis, Inc.OSI Pharmaceuticals, Inc.Oxford GlycoSciences Plc.Oxigene, Inc.Peptech Ltd.Pharming Group NVPolydex Pharmaceuticals Ltd.Praecis Pharmaceuticals, Inc.Progenics Pharmaceuticals, Inc.Protein Design Labs, Inc.Regeneron Pharmaceuticals, Inc.Ribozyme Pharmaceuticals, Inc.SangStat Medical Corp.SciClone Pharmaceuticals, Inc.Scios, Inc.Senetek Plc.Targeted Genetics Corp.Texas Biotechnology Corp.The Immune Response Corp.Trimeris, Inc.Tularik, Inc.
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
Vernalis Group Plc.Vertex Pharmaceuticals, Inc.Vical, Inc.Vitrolife ABXoma Ltd.ZymoGenetics, Inc.
Key Market Participants (cont’d)
© Copyright 2002 Frost & Sullivan. All Rights Reserved.
• Call toll free 877 GO FROST
(877.463.7876)
• Fax toll free 888.690.3329
• E-mail [email protected]
• Visit www.frost.com
For More Information
